Finnish healthcare group Mehiläinen, owned by CVC Capital Partners, which announced the acquisition of Regina Maria, must comply with several commitments negotiated with the Romanian Competition Council in order to secure approval for the deal. The authority reviewed the operation and concluded that it could affect competition in the market for assisted human reproduction services, potentially leading to price increases.
To address these concerns, Mehiläinen Oy agreed to a series of obligations. For three years, the company will cap prices for assisted reproduction procedures offered in clinics located in Bucharest, Brașov and Constanța, except for adjustments linked to annual inflation or justified cost changes such as taxes or doctors’ fees.
Read full article here: turnovernews.com
Photo: Helsingin Sanomat
UK
IT
ES
DE
FR
RO
PT
HU
